Shifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on ...

At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macu ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

A machine learning model incorporating treated astigmatism and nuanced inputs is advancing the precision and personalization ...

Rishi Singh, MD, discusses faricimab's real-world effectiveness in treating diabetic macular edema, highlighting improved ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The trial assessed the Valeda Light Delivery System in patients with dry (non-neovascular) age-related macular degeneration ...

NCX 470, Nicox’s lead clinical product candidate, is a novel NO-donating bimatoprost eye drop with a dual mechanism of action ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A recent study reveals how geographic atrophy affects patients' vision and quality of life, highlighting their coping ...

New research reveals how low blood sugar can damage the retina in diabetes, highlighting potential treatments targeting ...

CCOI transforms ophthalmic innovation by uniting stakeholders, streamlining processes, and prioritizing patient perspectives ...